EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSSTUG00000012706
Gene Symbol: DHCR24
3 Cross references
202 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSSTUG00000005302
Gene Symbol: DHCR24
1 Cross references
202 Possible Orthologues:

26s Proteasome Complex Subunit Sem1-Like

Ensembl ID : ENSSTUG00000041359
Gene Symbol: LOC115175516
3 Cross references
149 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 1-Like

Ensembl ID : ENSSTUG00000026660
Gene Symbol: LOC115157960
3 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSSTUG00000000973
Gene Symbol: LOC115201051
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b-Like

Ensembl ID : ENSSTUG00000035992
Gene Symbol: LOC115158466
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 12

Ensembl ID : ENSSTUG00000031253
Gene Symbol: LOC115208595
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 12-Like

Ensembl ID : ENSSTUG00000033219
Gene Symbol: LOC115178824
3 Cross references
211 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 13-Like

Ensembl ID : ENSSTUG00000035024
Gene Symbol: LOC115166718
3 Cross references
215 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 13-Like

Ensembl ID : ENSSTUG00000001588
Gene Symbol: LOC115203600
3 Cross references
215 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 14

Ensembl ID : ENSSTUG00000051136
Gene Symbol: LOC115179358
3 Cross references
205 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 14

Ensembl ID : ENSSTUG00000017429
Gene Symbol: LOC115196096
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).